Skip to main content
. 2015 Aug 20;11(11):2705–2715. doi: 10.1080/21645515.2015.1019186

Figure 4.

Figure 4.

AdCA trial: ex vivo ELISpot IFN-γ activities to CSP and AMA1. The associations of fold-changes of pre-CHMI and post-CHMI activities with pre-CHMI activities are shown as log-transformed values, and the dotted line represents no-change. The shaded box shows ±1.5 range. (A) CSP: there was a significant negative association between fold-change and pre-CHMI activities; activities of all 13/17 positive before CHMI fell after CHMI. (B) AMA1: although activities of all 17/17 subjects that were positive pre-CHMI all fell after CHMI, there was no relationship between fold-change and pre-CHMI activities as only 10/17 were greater than −1.5.